Global Microneedle Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 89
Published Date: 04 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Microneedle Flu Vaccine market size was valued at USD 1463.2 million in 2023 and is forecast to a readjusted size of USD 2095.3 million by 2030 with a CAGR of 5.3% during review period.
Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Microneedle Flu Vaccine industry chain, the market status of Influenza A (Solid Microneedle, Hollow Microneedle), Influenza B (Solid Microneedle, Hollow Microneedle), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Microneedle Flu Vaccine.
Regionally, the report analyzes the Microneedle Flu Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Microneedle Flu Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Microneedle Flu Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Microneedle Flu Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Dose), revenue generated, and market share of different by Type (e.g., Solid Microneedle, Hollow Microneedle).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Microneedle Flu Vaccine market.
Regional Analysis: The report involves examining the Microneedle Flu Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Microneedle Flu Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Microneedle Flu Vaccine:
Company Analysis: Report covers individual Microneedle Flu Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Microneedle Flu Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Influenza A, Influenza B).
Technology Analysis: Report covers specific technologies relevant to Microneedle Flu Vaccine. It assesses the current state, advancements, and potential future developments in Microneedle Flu Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Microneedle Flu Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Microneedle Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Solid Microneedle
Hollow Microneedle
Coated Microneedle
Dissolving Microneedle
Market segment by Application
Influenza A
Influenza B
Major players covered
Sanofi
GC Pharma
Debiotech
NanoPass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Microneedle Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Microneedle Flu Vaccine, with price, sales, revenue and global market share of Microneedle Flu Vaccine from 2019 to 2024.
Chapter 3, the Microneedle Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Microneedle Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Microneedle Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Microneedle Flu Vaccine.
Chapter 14 and 15, to describe Microneedle Flu Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Microneedle Flu Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Microneedle Flu Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Solid Microneedle
1.3.3 Hollow Microneedle
1.3.4 Coated Microneedle
1.3.5 Dissolving Microneedle
1.4 Market Analysis by Application
1.4.1 Overview: Global Microneedle Flu Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Influenza A
1.4.3 Influenza B
1.5 Global Microneedle Flu Vaccine Market Size & Forecast
1.5.1 Global Microneedle Flu Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Microneedle Flu Vaccine Sales Quantity (2019-2030)
1.5.3 Global Microneedle Flu Vaccine Average Price (2019-2030)
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Microneedle Flu Vaccine Product and Services
2.1.4 Sanofi Microneedle Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Sanofi Recent Developments/Updates
2.2 GC Pharma
2.2.1 GC Pharma Details
2.2.2 GC Pharma Major Business
2.2.3 GC Pharma Microneedle Flu Vaccine Product and Services
2.2.4 GC Pharma Microneedle Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GC Pharma Recent Developments/Updates
2.3 Debiotech
2.3.1 Debiotech Details
2.3.2 Debiotech Major Business
2.3.3 Debiotech Microneedle Flu Vaccine Product and Services
2.3.4 Debiotech Microneedle Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Debiotech Recent Developments/Updates
2.4 NanoPass Technologies
2.4.1 NanoPass Technologies Details
2.4.2 NanoPass Technologies Major Business
2.4.3 NanoPass Technologies Microneedle Flu Vaccine Product and Services
2.4.4 NanoPass Technologies Microneedle Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 NanoPass Technologies Recent Developments/Updates
2.5 Corium International
2.5.1 Corium International Details
2.5.2 Corium International Major Business
2.5.3 Corium International Microneedle Flu Vaccine Product and Services
2.5.4 Corium International Microneedle Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Corium International Recent Developments/Updates
2.6 Becton Dickinson and Company
2.6.1 Becton Dickinson and Company Details
2.6.2 Becton Dickinson and Company Major Business
2.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Product and Services
2.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Becton Dickinson and Company Recent Developments/Updates
2.7 FluGen
2.7.1 FluGen Details
2.7.2 FluGen Major Business
2.7.3 FluGen Microneedle Flu Vaccine Product and Services
2.7.4 FluGen Microneedle Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 FluGen Recent Developments/Updates
2.8 CosMED Pharmaceuticals
2.8.1 CosMED Pharmaceuticals Details
2.8.2 CosMED Pharmaceuticals Major Business
2.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Product and Services
2.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 CosMED Pharmaceuticals Recent Developments/Updates
2.9 Microdermics and OraSure Technologies
2.9.1 Microdermics and OraSure Technologies Details
2.9.2 Microdermics and OraSure Technologies Major Business
2.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product and Services
2.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Microdermics and OraSure Technologies Recent Developments/Updates
3.1 Global Microneedle Flu Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Microneedle Flu Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Microneedle Flu Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Microneedle Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Microneedle Flu Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Microneedle Flu Vaccine Manufacturer Market Share in 2023
3.5 Microneedle Flu Vaccine Market: Overall Company Footprint Analysis
3.5.1 Microneedle Flu Vaccine Market: Region Footprint
3.5.2 Microneedle Flu Vaccine Market: Company Product Type Footprint
3.5.3 Microneedle Flu Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Microneedle Flu Vaccine Market Size by Region
4.1.1 Global Microneedle Flu Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Microneedle Flu Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Microneedle Flu Vaccine Average Price by Region (2019-2030)
4.2 North America Microneedle Flu Vaccine Consumption Value (2019-2030)
4.3 Europe Microneedle Flu Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Microneedle Flu Vaccine Consumption Value (2019-2030)
4.5 South America Microneedle Flu Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Microneedle Flu Vaccine Consumption Value (2019-2030)
5.1 Global Microneedle Flu Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Microneedle Flu Vaccine Consumption Value by Type (2019-2030)
5.3 Global Microneedle Flu Vaccine Average Price by Type (2019-2030)
6.1 Global Microneedle Flu Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Microneedle Flu Vaccine Consumption Value by Application (2019-2030)
6.3 Global Microneedle Flu Vaccine Average Price by Application (2019-2030)
7.1 North America Microneedle Flu Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Microneedle Flu Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Microneedle Flu Vaccine Market Size by Country
7.3.1 North America Microneedle Flu Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Microneedle Flu Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Microneedle Flu Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Microneedle Flu Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Microneedle Flu Vaccine Market Size by Country
8.3.1 Europe Microneedle Flu Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Microneedle Flu Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Microneedle Flu Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Microneedle Flu Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Microneedle Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Microneedle Flu Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Microneedle Flu Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Microneedle Flu Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Microneedle Flu Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Microneedle Flu Vaccine Market Size by Country
10.3.1 South America Microneedle Flu Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Microneedle Flu Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Microneedle Flu Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Microneedle Flu Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Microneedle Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Microneedle Flu Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Microneedle Flu Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Microneedle Flu Vaccine Market Drivers
12.2 Microneedle Flu Vaccine Market Restraints
12.3 Microneedle Flu Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Microneedle Flu Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Microneedle Flu Vaccine
13.3 Microneedle Flu Vaccine Production Process
13.4 Microneedle Flu Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Microneedle Flu Vaccine Typical Distributors
14.3 Microneedle Flu Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Microneedle Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Microneedle Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Microneedle Flu Vaccine Product and Services
Table 6. Sanofi Microneedle Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Sanofi Recent Developments/Updates
Table 8. GC Pharma Basic Information, Manufacturing Base and Competitors
Table 9. GC Pharma Major Business
Table 10. GC Pharma Microneedle Flu Vaccine Product and Services
Table 11. GC Pharma Microneedle Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GC Pharma Recent Developments/Updates
Table 13. Debiotech Basic Information, Manufacturing Base and Competitors
Table 14. Debiotech Major Business
Table 15. Debiotech Microneedle Flu Vaccine Product and Services
Table 16. Debiotech Microneedle Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Debiotech Recent Developments/Updates
Table 18. NanoPass Technologies Basic Information, Manufacturing Base and Competitors
Table 19. NanoPass Technologies Major Business
Table 20. NanoPass Technologies Microneedle Flu Vaccine Product and Services
Table 21. NanoPass Technologies Microneedle Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. NanoPass Technologies Recent Developments/Updates
Table 23. Corium International Basic Information, Manufacturing Base and Competitors
Table 24. Corium International Major Business
Table 25. Corium International Microneedle Flu Vaccine Product and Services
Table 26. Corium International Microneedle Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Corium International Recent Developments/Updates
Table 28. Becton Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 29. Becton Dickinson and Company Major Business
Table 30. Becton Dickinson and Company Microneedle Flu Vaccine Product and Services
Table 31. Becton Dickinson and Company Microneedle Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Becton Dickinson and Company Recent Developments/Updates
Table 33. FluGen Basic Information, Manufacturing Base and Competitors
Table 34. FluGen Major Business
Table 35. FluGen Microneedle Flu Vaccine Product and Services
Table 36. FluGen Microneedle Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. FluGen Recent Developments/Updates
Table 38. CosMED Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. CosMED Pharmaceuticals Major Business
Table 40. CosMED Pharmaceuticals Microneedle Flu Vaccine Product and Services
Table 41. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. CosMED Pharmaceuticals Recent Developments/Updates
Table 43. Microdermics and OraSure Technologies Basic Information, Manufacturing Base and Competitors
Table 44. Microdermics and OraSure Technologies Major Business
Table 45. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product and Services
Table 46. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Microdermics and OraSure Technologies Recent Developments/Updates
Table 48. Global Microneedle Flu Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Dose)
Table 49. Global Microneedle Flu Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Microneedle Flu Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 51. Market Position of Manufacturers in Microneedle Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Microneedle Flu Vaccine Production Site of Key Manufacturer
Table 53. Microneedle Flu Vaccine Market: Company Product Type Footprint
Table 54. Microneedle Flu Vaccine Market: Company Product Application Footprint
Table 55. Microneedle Flu Vaccine New Market Entrants and Barriers to Market Entry
Table 56. Microneedle Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Microneedle Flu Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
Table 58. Global Microneedle Flu Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
Table 59. Global Microneedle Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Microneedle Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Microneedle Flu Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 62. Global Microneedle Flu Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 63. Global Microneedle Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 64. Global Microneedle Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 65. Global Microneedle Flu Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Microneedle Flu Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Microneedle Flu Vaccine Average Price by Type (2019-2024) & (US$/Dose)
Table 68. Global Microneedle Flu Vaccine Average Price by Type (2025-2030) & (US$/Dose)
Table 69. Global Microneedle Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 70. Global Microneedle Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 71. Global Microneedle Flu Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Microneedle Flu Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Microneedle Flu Vaccine Average Price by Application (2019-2024) & (US$/Dose)
Table 74. Global Microneedle Flu Vaccine Average Price by Application (2025-2030) & (US$/Dose)
Table 75. North America Microneedle Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 76. North America Microneedle Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 77. North America Microneedle Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 78. North America Microneedle Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 79. North America Microneedle Flu Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
Table 80. North America Microneedle Flu Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
Table 81. North America Microneedle Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Microneedle Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Microneedle Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 84. Europe Microneedle Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 85. Europe Microneedle Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 86. Europe Microneedle Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 87. Europe Microneedle Flu Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
Table 88. Europe Microneedle Flu Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
Table 89. Europe Microneedle Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Microneedle Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Microneedle Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 92. Asia-Pacific Microneedle Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 93. Asia-Pacific Microneedle Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 94. Asia-Pacific Microneedle Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 95. Asia-Pacific Microneedle Flu Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
Table 96. Asia-Pacific Microneedle Flu Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
Table 97. Asia-Pacific Microneedle Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Microneedle Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Microneedle Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 100. South America Microneedle Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 101. South America Microneedle Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 102. South America Microneedle Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 103. South America Microneedle Flu Vaccine Sales Quantity by Country (2019-2024) & (K Dose)
Table 104. South America Microneedle Flu Vaccine Sales Quantity by Country (2025-2030) & (K Dose)
Table 105. South America Microneedle Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Microneedle Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Microneedle Flu Vaccine Sales Quantity by Type (2019-2024) & (K Dose)
Table 108. Middle East & Africa Microneedle Flu Vaccine Sales Quantity by Type (2025-2030) & (K Dose)
Table 109. Middle East & Africa Microneedle Flu Vaccine Sales Quantity by Application (2019-2024) & (K Dose)
Table 110. Middle East & Africa Microneedle Flu Vaccine Sales Quantity by Application (2025-2030) & (K Dose)
Table 111. Middle East & Africa Microneedle Flu Vaccine Sales Quantity by Region (2019-2024) & (K Dose)
Table 112. Middle East & Africa Microneedle Flu Vaccine Sales Quantity by Region (2025-2030) & (K Dose)
Table 113. Middle East & Africa Microneedle Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Microneedle Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Microneedle Flu Vaccine Raw Material
Table 116. Key Manufacturers of Microneedle Flu Vaccine Raw Materials
Table 117. Microneedle Flu Vaccine Typical Distributors
Table 118. Microneedle Flu Vaccine Typical Customers
List of Figures
Figure 1. Microneedle Flu Vaccine Picture
Figure 2. Global Microneedle Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Microneedle Flu Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Solid Microneedle Examples
Figure 5. Hollow Microneedle Examples
Figure 6. Coated Microneedle Examples
Figure 7. Dissolving Microneedle Examples
Figure 8. Global Microneedle Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Microneedle Flu Vaccine Consumption Value Market Share by Application in 2023
Figure 10. Influenza A Examples
Figure 11. Influenza B Examples
Figure 12. Global Microneedle Flu Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Microneedle Flu Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Microneedle Flu Vaccine Sales Quantity (2019-2030) & (K Dose)
Figure 15. Global Microneedle Flu Vaccine Average Price (2019-2030) & (US$/Dose)
Figure 16. Global Microneedle Flu Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Microneedle Flu Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Microneedle Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Microneedle Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Microneedle Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Microneedle Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Microneedle Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Microneedle Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Microneedle Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Microneedle Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Microneedle Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Microneedle Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Microneedle Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Microneedle Flu Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Microneedle Flu Vaccine Average Price by Type (2019-2030) & (US$/Dose)
Figure 31. Global Microneedle Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Microneedle Flu Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Microneedle Flu Vaccine Average Price by Application (2019-2030) & (US$/Dose)
Figure 34. North America Microneedle Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Microneedle Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Microneedle Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Microneedle Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Microneedle Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Microneedle Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Microneedle Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Microneedle Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Microneedle Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Microneedle Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Microneedle Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Microneedle Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 54. China Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Microneedle Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Microneedle Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Microneedle Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Microneedle Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Microneedle Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Microneedle Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Microneedle Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Microneedle Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Microneedle Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Microneedle Flu Vaccine Market Drivers
Figure 75. Microneedle Flu Vaccine Market Restraints
Figure 76. Microneedle Flu Vaccine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Microneedle Flu Vaccine in 2023
Figure 79. Manufacturing Process Analysis of Microneedle Flu Vaccine
Figure 80. Microneedle Flu Vaccine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sanofi GC Pharma Debiotech NanoPass Technologies Corium International Becton Dickinson and Company FluGen CosMED Pharmaceuticals Microdermics and OraSure Technologies
Related Reports
01 Apr 2021
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
